U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
86413
Name Type Language
NARATUXIMAB EMTANSINE
INN   WHO-DD  
INN  
Official Name English
IMGN 529 [WHO-DD]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENSCD37 (TETRASPANIN-26, TSPAN26)), CHIMERIC MONOCLONAL ANTIBODY CONJUGATED TO MAYTANSINOID DM1
Common Name English
naratuximab emtansine [INN]
Common Name English
DEBIO-1562
Code English
Naratuximab emtansine [WHO-DD]
Common Name English
IMGN529
Code English
IMGN-529
Code English
K7153A-SMCC-DM1
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 518016
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
Code System Code Type Description
INN
10238
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
PRIMARY
CAS
1607824-64-5
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
PRIMARY
DRUG BANK
DB15453
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
PRIMARY
NCI_THESAURUS
C100101
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
PRIMARY
FDA UNII
WE1X5A83B9
Created by admin on Sat Dec 16 11:17:26 UTC 2023 , Edited by admin on Sat Dec 16 11:17:26 UTC 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966